Duchenne drugs

posted on October 1, 2010 - 12:25pm
Featured in this issue: First U.S. exon-skipping trial opens * Utah researchers seek families with Ullrich CMD or Bethlem myopathy * Acceleron receives Fast Track, Orphan Drug designations for ACE031 * BioMarin abandons BMN195 development

New content is being added every day. Please check back again.